Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 23
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Dentsply Sirona Inc
XRAY
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$9.50
0.42
4.63%
Dern. MÀJ: Oct 22, 6:55 PM
$9.46
0.38
4.19%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Dividendes
Comparer
Options
Rapport sur les stocks
Privacy Manager
Résultats:
Résultats Q3 2026 dans dans 13 jours à partir de maintenant le jeu. nov. 5th, après la fermeture du marché
Dentsply Sirona Financials
Dentsply Sirona (XRAY) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Dentsply Sirona Affirms FY2026 Adj EPS Guidance of $1.40-$1.50 vs $1.42 Est; Affirms FY2026 Sales Guidance of $3.500B-$3.600B vs $3.582B Est
Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.42 analyst estimate. Affirms FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500 billion-$3.600 billion
Benzinga Newsdesk
PRO
Dentsply Sirona Q2 Adj. EPS $0.52 Beats $0.35 Estimate, Sales $898.000M Beat $889.810M Estimate
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.35 by 48.57 percent. This is unchanged from the same period last year. The company reported
Benzinga Newsdesk
PRO
Dentsply Sirona Affirms FY2026 Adj EPS Guidance of $1.40-$1.50 vs $1.43 Est; Affirms FY2026 Sales Guidance of $3.500B-$3.600B vs $3.578B Est
Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.43 analyst estimate. Affirms FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500 billion-$3.600 billion vs
Benzinga Newsdesk
PRO
Dentsply Sirona Q1 Adj. EPS $0.27 Misses $0.28 Estimate, Sales $880.000M Beat $842.589M Estimate
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.28 by 3.57 percent. This is a 37.21 percent decrease over earnings of $0.43 per share from
Benzinga Newsdesk
Earnings Scheduled For May 5, 2026
Benzinga Insights
Earnings Summary: Dentsply Sirona Q4
Benzinga Insights
